Meena B Bansal (Meena Bansal, M B Bansal)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Insulin Resistance

Multiple Myeloma

Helicobacter Pylori

Top Venues

Alimentary pharmacology & therapeutics

Hepatology communications

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

S K Bansal, Meena B Bansal
Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH-Authors' reply. Alimentary pharmacology & therapeutics 60 (5) (2024)
Robert Chen, Ben Omega Petrazzini, Girish Nitin Nadkarni, Ghislain Rocheleau, Meena B Bansal, Ron Do
Comparison of blood-based liver fibrosis scores in the Mount Sinai Health System, MASLD Registry, and NHANES 2017-2020 study. Hepatology communications 8 (9) (2024)
Robert Chen, Ben Omega Petrazzini, Girish Nitin Nadkarni, Ghislain Rocheleau, Meena B Bansal, Ron Do
Comparison of blood-based liver fibrosis scores in the Mount Sinai Health System, MASLD Registry, and NHANES 2017-2020 study. Hepatology communications 8 (9) (2024)
S K Bansal, Meena B Bansal
'Letter: Role of Helicobacter pylori and metabolic syndrome-related insulin resistance and lipotoxicity in the pathogenesis of MAFLD and MASH-Authors' reply. Alimentary pharmacology & therapeutics (2024)
Robert Chen, Ben Omega Petrazzini, Girish Nitin Nadkarni, Ghislain Rocheleau, Meena B Bansal, Ron Do
Comparison of blood-based liver fibrosis scores in the Mount Sinai Health System, MASLD Registry, and NHANES 2017-2020 study. Hepatology communications 8 (9) (2024)
Shalini K Bansal, Meena B Bansal
Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Alimentary pharmacology & therapeutics (2024)
Shalini K Bansal, Meena B Bansal
Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Alimentary pharmacology & therapeutics (2024)
Shalini K Bansal, Meena B Bansal
Review article: Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Alimentary pharmacology & therapeutics (2024)
Shalini K Bansal, Meena B Bansal
Pathogenesis of MASLD and MASH - role of insulin resistance and lipotoxicity. Alimentary pharmacology & therapeutics (2024)
Noa Biran, Elli Gourna Paleoudis, Rena Feinman, David H Vesole, Joshua Zenreich, Shuqi Wang, Jaeil Ahn, Meena B Bansal, Scott Douglas Rowley, Michele L Donato, Andrew L Pecora, Joshua Richter, Palka Anand, Laura McBride, Kristin Ivanovski, Robert Korngold, David S Siegel
Pembrolizumab, lenalidomide and dexamethasone post autologous transplant in patients with high-risk multiple myeloma. American journal of hematology 96 (11) (2021)